These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 35073624)

  • 1. Outcomes of neonatal chylous effusions: A 20-year west-Australian tertiary center experience.
    Anvekar A; Athalye-Jape G; Panchal H; Rao S; Kohan R
    Lymphology; 2021; 54(4):204-213. PubMed ID: 35073624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical features and outcomes of congenital chylothorax: a single tertiary medical center experience in China.
    Wang B; Feng Y; Guo Y; Kan Q; Zou Y; Wu Y; Zheng M; Cheng R
    J Cardiothorac Surg; 2022 Oct; 17(1):276. PubMed ID: 36303149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of Propranolol in the Treatment of Chylous Effusions in Infants.
    Mitchell K; Weiner A; Ramsay P; Sahni M
    Pediatrics; 2021 Jul; 148(1):. PubMed ID: 34187907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Congenital Chylothorax: A Unique Presentation of Nonimmune Hydrops Fetalis in a Preterm Infant.
    Brock WW; Bradshaw WT
    Adv Neonatal Care; 2016 Apr; 16(2):114-23. PubMed ID: 26945279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Congenital fetal and neonatal visceral chylous effusions: neonatal chylothorax and chylous ascites revisited. A multicenter retrospective study.
    Bellini C; Ergaz Z; Radicioni M; Forner-Cordero I; Witte M; Perotti G; Figar T; Tubaldi L; Camerini P; Bar-Oz B; Yatsiv I; Arad I; Traverso F; Bellini T; Boccardo F; Campisi C; Dalmonte P; Vercellino N; Manikanti S; Bonioli E
    Lymphology; 2012 Sep; 45(3):91-102. PubMed ID: 23342929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcome of neonatal chylous effusions: what do you tell the parents? A 10-year experience in a community hospital.
    Bengtsson BO
    Am J Perinatol; 2014 Dec; 31(12):1037-42. PubMed ID: 24566754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Octreotide for chylous effusions in congenital diaphragmatic hernia.
    Landis MW; Butler D; Lim FY; Keswani S; Frischer J; Haberman B; Kingma PS
    J Pediatr Surg; 2013 Nov; 48(11):2226-9. PubMed ID: 24210190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sirolimus efficacy in the treatment of critically ill infants with congenital primary chylous effusions.
    Agarwal S; Anderson BK; Mahajan P; Fernandes CJ; Margolin JF; Iacobas I
    Pediatr Blood Cancer; 2022 Feb; 69(2):e29510. PubMed ID: 34889518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A clinical analysis of neonatal chylous effusions].
    Lu DF; Tong XM
    Zhongguo Dang Dai Er Ke Za Zhi; 2020 Apr; 22(4):328-333. PubMed ID: 32312370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Medical treatment of chylous effusions in newborn infants. Apropos of 3 cases].
    Jernite M; Donato L; Favre R; Haddad J; Esposito M; Messer J
    Arch Fr Pediatr; 1992 Nov; 49(9):811-4. PubMed ID: 1300971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Octreotide Use in Neonates: A Case Series.
    Zaki SA; Krishnamurthy MB; Malhotra A
    Drugs R D; 2018 Sep; 18(3):191-198. PubMed ID: 29948779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Congenital chylothorax: associations and neonatal outcomes.
    Downie L; Sasi A; Malhotra A
    J Paediatr Child Health; 2014 Mar; 50(3):234-8. PubMed ID: 24372911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Necrotising enterocolitis in a newborn infant treated with octreotide for chylous effusion: is octreotide safe?
    Chandran S; Agarwal A; Llanora GV; Chua MC
    BMJ Case Rep; 2020 Feb; 13(2):. PubMed ID: 32051156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Congenital chylothorax: a prospective nationwide epidemiological study in Germany.
    Bialkowski A; Poets CF; Franz AR;
    Arch Dis Child Fetal Neonatal Ed; 2015 Mar; 100(2):F169-72. PubMed ID: 25480460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of somatostatin/octreotide treatment in neonates with congenital chylothorax.
    Yin R; Zhang R; Wang J; Yuan L; Hu L; Jiang S; Chen C; Cao Y
    Medicine (Baltimore); 2017 Jul; 96(29):e7594. PubMed ID: 28723800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of chylothorax and chylopericardium in pediatric patients: experiences at Siriraj Hospital, Bangkok.
    Densupsoontorn NS; Jirapinyo P; Wongarn R; Thamonsiri N; Nana A; Laohaprasitiporn D; Soongswang J; Durongpisitkul KD; Pornvilawan SA
    Asia Pac J Clin Nutr; 2005; 14(2):182-7. PubMed ID: 15927938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pleural effusions in the neonate.
    Rocha G; Fernandes P; Rocha P; Quintas C; Martins T; Proença E
    Acta Paediatr; 2006 Jul; 95(7):791-8. PubMed ID: 16801173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Octreotide for congenital and acquired chylothorax in newborns: A systematic review.
    Bellini C; Cabano R; De Angelis LC; Bellini T; Calevo MG; Gandullia P; Ramenghi LA
    J Paediatr Child Health; 2018 Aug; 54(8):840-847. PubMed ID: 29602276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Congenital chylothorax.
    Al-Tawil K; Ahmed G; Al-Hathal M; Al-Jarallah Y; Campbell N
    Am J Perinatol; 2000; 17(3):121-6. PubMed ID: 11012135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Somatostatin analog (octreotide) in management of neonatal postoperative chylothorax: is it safe?
    Mohseni-Bod H; Macrae D; Slavik Z
    Pediatr Crit Care Med; 2004 Jul; 5(4):356-7. PubMed ID: 15215005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.